Institute for International Research

Deadline to Submit Proposals is Friday, October 10, 2008

Are you interested in speaking at Japan's premier drug discovery & development event of the year? If so, now is your opportunity to submit a speaker proposal for IBC's 4th annual Drug Discovery & Development of Innovative Therapeutics taking place on June 1-3, 2009 at the Keio Plaza Hotel in Tokyo, Japan. If you are accepted as a confirmed speaker, you will receive a complimentary conference pass to this event (a US$1499+ value!).

Simultaneous translation (Japanese/English) will be provided during the conference, so speakers may give their talks in either Japanese or English. However, we ask that you please submit a written summary of the proposed presentation in English.

We are currently accepting proposals for speaking presentations in the following topic areas that will form the basis of the Drug Discovery & Development of Innovative Therapeutics program:

1. New Approaches and Technologies in Drug Discovery
   • New technologies for lead optimization and compound selection
   • Cell-based phenotypic assays and disease models using primary human cells and tissues
   • Fragment-based lead discovery
   • High quality, high content biology to understand targets/compounds in disease
2. Strategies to Accelerate Compounds from Discovery to the Clinic and POC
   • Biomarker qualification and validation in cancer and other diseases
   • Preclinical/clinical case studies in oncology, metabolic disease, inflammation, CNS
   • Molecular imaging techniques
   • Emerging technologies from discovery to Phase 1
3. Translational Medicine
   • Approaches to confirm target engagement and compound interaction
   • Case studies of translational medicine applied in different therapeutic areas
   • Funding translational research activities in academia/government
   • Techniques for patient selection and stratification in clinical trials
4. The Next Wave of Antibody and Protein-Based Therapeutics
   • Next generation antibodies, antibody fragments and antibody-like scaffolds
   • RNAi therapeutics and technologies
   • Special strategies for orphan drugs
   • Combination cancer therapies
   • Stem cell-based therapies
   • Immunogenicity prediction
5. Making Win-Win Drug Development Partnerships
   • Early clinical development deals to maximize value for both partners
   • New business models for collaborating on win-win partnerships
   • Case studies of successful partnerships: deal structures and terms that work
   • Capturing the global market through partnerships for your drug
   • Improving Japan-US-Euro Partnering/Deal-Flow
6. Finding Innovation and New Technologies/Molecules in Discovery and Development
   • Industry-academic collaborations to find technology innovations and products
   • Working with bioventures and seed companies who have innovative R&D approaches
   • What are mid-size pharmas doing to accelerate innovative drugs?

Proposals will be selected for oral presentations primarily based on evidence in the abstract showing novelty, a practical and unique application or a detailed case study of lessons learned from a drug discovery & development project.

To submit your abstract, please fill out the following submission form by October 10, 2008.